Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Southwest Oncology Group
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group Identifier:
First received: August 24, 2012
Last updated: July 25, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2030
  Estimated Primary Completion Date: December 2022 (Final data collection date for primary outcome measure)